An Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia
NCT ID: NCT03539276
Last Updated: 2018-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2014-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Value Champions Reduce Inappropriate Prescribing for People With Dementia?
NCT05359679
An Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults
NCT01148186
Optimizing Care for Patients With Dementia
NCT03442322
Understanding Benzodiazepine and Non-benzodiazepine Sedative Use
NCT02833272
Impact in Older Adults of Reducing Anticholinergic and Sedative Rx Burden on Physical Function Measured by Wearables
NCT05735379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-intervention
Usual care
No interventions assigned to this group
Post-intervention
One 90-minute interdisciplinary knowledge exchange including the provision of a validated list of appropriate and inappropriate medications for severe dementia long-term care residents.
Knowledge exchange
OptimaMed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Knowledge exchange
OptimaMed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* severe dementia
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University
OTHER
Université de Montréal
OTHER
Université de Sherbrooke
OTHER
Fonds de la Recherche en Santé du Québec
OTHER_GOV
CHU de Quebec-Universite Laval
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dre Edeltraut Kröger
Adjunct professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edeltraut Kröger, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
Québec, , Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kroger E, Wilchesky M, Marcotte M, Voyer P, Morin M, Champoux N, Monette J, Aubin M, Durand PJ, Verreault R, Arcand M. Medication Use Among Nursing Home Residents With Severe Dementia: Identifying Categories of Appropriateness and Elements of a Successful Intervention. J Am Med Dir Assoc. 2015 Jul 1;16(7):629.e1-17. doi: 10.1016/j.jamda.2015.04.002. Epub 2015 May 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OptimaMed-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.